Avantor, Inc.

NYSE:AVTR

Medical - Instruments & Supplies

Healthcare
$15.37 +0.69%

+$0.07 today

Market cap
$10.41B
Beta
0.96
P/E (TTM)
-11.7
EPS (TTM)
-$0.81
52W Low $7.27High $15.93

Volume 5.94M

Average 9.44M

AVTR Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Avantor, Inc.NYSE: AVTR

Retained Earnings · Q2 FY2026 · quarter ended Jun 2026

Retained earnings falls 24.8% from a year ago

Retained earnings stood at $1.75B at the end of Q2 FY2026, down 24.8% from a year earlier and up 2.2% from the prior quarter. Over 3 fiscal years it compounded at +12.6% a year.

Context

  • Retained earnings amounted to 15.1% of total assets at the end of Q2 FY2026, down 3.1 pp from a year earlier.
  • Retained earnings increased in 2 of the last 3 fiscal years.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -24.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.75B+2.2% QoQ
Last fiscal yearDec 2025
$1.67B-24.1% YoY
Year agoJun 2025
$2.33B-24.8% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-24.8%——
1 year-24.1%——
3-year CAGR+12.6%——
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
1.67B USD
Year-over-year change
-24.1%
4-year CAGR
+36.4%

Retained Earnings vs competitors

How AVTR compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -24.8% is the 7th highest of 8, against a peer median of +2.9%.
  • Retained earnings amounts to 15.1% of total assets for AVTR, versus a peer median of 63.0%.
AVTR Competitors
Retained Earnings for AVTR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DHRDanaher CorporationSep 2026$49.18B USD+7.1%+6.1%52.7%
BIOBio-Rad Laboratories, Inc.Jun 2026$8.02B USD+2.9%-6.2%78.2%
WSTWest Pharmaceutical Services, Inc.Jun 2026$4.62B USD+11.7%+13.6%113.4%
AVTRAvantor, Inc.Jun 2026$1.75B USD-24.8%+12.6%15.1%
CRLCharles River Laboratories International, Inc.Jun 2026$1.37B USD-27.4%-1.0%18.2%
AZTAAzenta, Inc.Sep 2026$1.25B USD-11.5%-8.6%73.3%
STVNStevanato Group S.p.A.Jun 2026€1.03B EUR—+12.0%39.3%
RGENRepligen CorporationJun 2026$469.59M USD+9.7%+4.7%15.9%
BLFSBioLife Solutions, Inc.Mar 2026-$338.51M USD-0.9%—84.4%
Peer median (excluding AVTR) —+2.9%+4.7%63.0%

Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents301.7M372.9M262.9M261.9M365.4M
Short-term Investments00000
Net Receivables1.22B1.22B1.15B1.03B1.07B
Inventory872M913.5M828.1M731.5M818.2M
Other Current Assets81.4M153.1M143.7M118.7M193M
Total Current Assets2.48B2.66B2.38B2.15B2.45B
Property, Plant & Equipment (Net)705.5M727M737.5M708.1M766.8M
Goodwill5.34B5.65B5.72B5.54B4.99B
Intangible Assets5.14B4.13B3.78B3.36B3.19B
Long-term Investments00000
Tax Assets00000
Other Non-current Assets233.1M293.5M358.3M360.4M396M
Total Non-current Assets11.42B10.81B10.59B9.97B9.34B
Total Assets13.9B13.46B12.97B12.11B11.79B
Account Payables755.1M758.2M625.9M662.8M741.7M
Short-term Debt45.2M364.2M259.9M821.1M30.8M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities600.7M486.5M544.3M475M559.1M
Total Current Liabilities1.45B1.66B1.48B2.01B1.38B
Long-term Debt6.98B5.92B5.28B3.23B3.92B
Deferred Tax Liabilities913M731.4M612.8M557.3M557.1M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities358.4M295.4M350.3M358.3M378.2M
Total Non-current Liabilities8.25B6.95B6.24B4.15B4.85B
Total Liabilities9.7B8.61B7.72B6.16B6.23B
Common Stock2.75B3.79B3.83B3.94B3.98B
Retained Earnings483.9M1.17B1.49B2.2B1.67B
Accumulated OCI(43.2M)(100.3M)(69M)(184M)(16.9M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity4.2B4.86B5.25B5.96B5.57B
Total Debt7.02B6.29B5.54B4.06B3.95B
Net Debt6.72B5.91B5.27B3.79B3.58B

Avantor, Inc.

NYSE:AVTR

Intrinsic Alpha fair value

Locked

Current Price

$15.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.